Abiomed Expands Heart Recovery Biz With New Circulatory Support Console
This article was originally published in The Gray Sheet
Executive Summary
Abiomed is banking on its iPulse console, approved by FDA Dec. 18, to drive sales across its full acute cardiac assist portfolio and provide entrée into the $200 million intra-aortic balloon market